Sumitomo Pharma closed today at ¥1,884.5 after a sharp multi month climb, with the stock up about 51% over the past quarter. The Q2 2027 earnings release just landed and the headline is simple. Profitability looks much thinner than the recent share price surge might suggest, with trailing net margin at 9.4% compared with 34.8%…
